Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification Number)
|
Title of each class:
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
☒
|
Smaller reporting company
|
|
Emerging growth company
|
|
1 |
|
1 |
|
21 |
|
39 |
|
39 |
|
39 |
|
39 |
|
41 |
|
41 | |
41 | |
41 | |
41 | |
41 | |
42 |
● |
general economic and business conditions, including changes in interest rates;
|
● |
prices of other EVs, costs associated with manufacturing EVs and other economic conditions;
|
● |
the effect of an outbreak of disease or similar public health threat, such as the COVID-19 pandemic, on the Company’s business (natural phenomena, including the
lingering effects of the COVID-19 pandemic);
|
● |
the impact of political unrest, natural disasters or other crises, terrorist acts, acts of war and/or military operations, and our ability to maintain or broaden
our business relationships and develop new relationships with strategic alliances, suppliers, customers, distributors or otherwise;
|
● |
the ability of our information technology systems or information security systems to operate effectively;
|
● |
actions by government authorities, including changes in government regulation;
|
● |
uncertainties associated with legal proceedings;
|
● |
changes in the size of the EV market;
|
● |
future decisions by management in response to changing conditions;
|
● |
the Company’s ability to execute prospective business plans;
|
● |
misjudgments in the course of preparing forward-looking statements;
|
● |
the Company’s ability to raise sufficient funds to carry out its proposed business plan;
|
● |
inability to keep up with advances in EV and battery technology;
|
● |
inability to design, develop, market and sell new EVs and services that address additional market opportunities to generate revenue and positive cash flows;
|
● |
dependency on certain key personnel and any inability to retain and attract qualified personnel;
|
● |
inexperience in mass-producing EVs;
|
● |
inability to succeed in establishing, maintaining and strengthening the Cenntro brand;
|
● |
disruption of supply or shortage of raw materials;
|
● |
the unavailability, reduction or elimination of government and economic incentives;
|
● |
failure to manage future growth effectively; and
|
● |
the other risks and uncertainties detailed from time to time in our filings with the Security and Exchange Commission (“SEC”), including but not limited to those described under
“Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K as amended for the year ended December 31, 2022, filed with the SEC on June 30, 2023 and as amended on July 6, 2023 (the “Form 10-K/A”).
|
For the Three Months
Ended June 30,
|
For the Six Months
Ended June 30,
|
|||||||||||||||||||
Note
|
2023
|
2022
|
2023
|
2022
|
||||||||||||||||
Net revenues
|
2(c)
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Cost of goods sold
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||||||
OPERATING EXPENSES:
|
||||||||||||||||||||
Selling and marketing expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
General and administrative expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Research and development expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Total operating expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Loss from operations
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
OTHER EXPENSE:
|
||||||||||||||||||||
Interest income (expense), net
|
|
|
(
|
)
|
|
|||||||||||||||
(Loss) income from long-term investment
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||
Impairment of long-term investment
|
7(1)
|
|
(
|
)
|
|
(
|
)
|
|
||||||||||||
Gain (loss) on redemption of convertible promissory notes
|
|
|
(
|
)
|
|
|||||||||||||||
Loss on exercise of warrants
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
|
|
|
|
||||||||||||||||
Change in fair value of equity securities
|
8
|
|
|
|
|
|||||||||||||||
Other (expense) income, net
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||
Loss before income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Income tax (expense) benefit
|
11
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||
Net loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Less: net loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Net loss attributable to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
$ |
(
|
)
|
$ |
(
|
)
|
||||||||
OTHER COMPREHENSIVE LOSS
|
||||||||||||||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Total comprehensive loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Total comprehensive loss to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
(
|
)
|
(
|
)
|
Note
|
June 30,
2023
|
December 31,
2022
|
||||||||||
(Unaudited)
|
||||||||||||
ASSETS
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||||||
Restricted cash
|
|
|
||||||||||
Accounts receivable, net
|
4
|
|
|
|||||||||
Inventories
|
5
|
|
|
|||||||||
Prepayment and other current assets
|
6
|
|
|
|||||||||
Deferred cost- current |
||||||||||||
|
16
|
|
|
|||||||||
Total current assets
|
|
|
||||||||||
Non-current assets:
|
||||||||||||
Long-term investment, net
|
7
|
|
|
|||||||||
Investment in equity securities
|
8
|
|
|
|||||||||
Property, plant and equipment, net
|
9
|
|
|
|||||||||
Intangible assets, net
|
10 |
|
|
|||||||||
Right-of-use assets
|
12
|
|
|
|||||||||
Deferred cost - non-current |
||||||||||||
Other non-current assets, net
|
|
|
||||||||||
Total non-current assets
|
|
|
||||||||||
Total Assets
|
$
|
|
$
|
|
||||||||
LIABILITIES AND EQUITY
|
||||||||||||
LIABILITIES
|
||||||||||||
Current liabilities:
|
||||||||||||
Accounts payable
|
$
|
|
$
|
|
||||||||
Accrued expenses and other current liabilities
|
|
|
||||||||||
Contractual liabilities
|
|
|
||||||||||
Operating lease liabilities, current
|
12
|
|
|
|||||||||
Convertible promissory notes
|
13
|
|
|
|||||||||
Deferred government grant, current
|
|
|
||||||||||
|
16
|
|
|
|||||||||
Total current liabilities
|
|
|
||||||||||
Non-current liabilities:
|
||||||||||||
Deferred government grant, non-current
|
|
|
||||||||||
Derivative liability - investor warrant
|
13
|
|
|
|||||||||
Derivative liability - placement agent warrant
|
13
|
|
|
|||||||||
Operating lease liabilities, non-current
|
12
|
|
|
|||||||||
Total non-current liabilities
|
|
|
||||||||||
Total Liabilities
|
$
|
|
$
|
|
||||||||
Commitments and contingencies
|
15
|
|||||||||||
EQUITY
|
||||||||||||
Ordinary shares (
|
|
|
||||||||||
Additional paid in capital
|
|
|
||||||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||||||
Total equity attributable to shareholders
|
|
|
||||||||||
Non-controlling interests
|
(
|
)
|
(
|
)
|
||||||||
Total Equity
|
$
|
|
$
|
|
||||||||
Total Liabilities and Equity
|
$
|
|
$
|
|
For the Six Months Ended June
30,
|
||||||||
2023
|
2022
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net cash used in operating activities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Purchase of equity investment
|
(
|
)
|
|
|||||
Purchase of plant and equipment
|
(
|
)
|
(
|
)
|
||||
Purchase of land use right and property
|
(
|
)
|
(
|
)
|
||||
Acquisition of CAE’s equity interests
|
(
|
)
|
(
|
)
|
||||
Cash acquired from acquisition of CAE
|
||||||||
Payment of expense for Acquisition of CAE’s equity interests
|
( |
) | ||||||
Proceeds from disposal of property, plant and equipment
|
|
|
||||||
Loans provided to third parties
|
(
|
)
|
(
|
)
|
||||
Repayment of loans from related parties
|
||||||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Repayment of loans to related parties
|
|
(
|
)
|
|||||
Repayment of loans to third parties
|
|
(
|
)
|
|||||
Purchase of CAE’s loan
|
|
(
|
)
|
|||||
Reduction of capital
|
|
(
|
)
|
|||||
Redemption of convertible promissory notes
|
(
|
)
|
|
|||||
Payment of expense for the reverse recapitalization
|
|
(
|
)
|
|||||
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
Effect of exchange rate changes on cash
|
(
|
)
|
(
|
)
|
||||
Net decrease in cash, cash equivalents and restricted cash
|
(
|
)
|
(
|
)
|
||||
Cash, cash equivalents and restricted cash at beginning of period
|
|
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
|
$
|
|
||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Interest paid
|
$
|
|
$
|
|
||||
Income tax paid
|
$ |
$ |
||||||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Right of use assets obtained in exchange for operating lease obligations
|
$ |
$ |
||||||
Cashless exercise of warrants
|
$
|
|
$
|
|
Ordinary shares
|
Additional
paid in capital
|
Accumulated
deficit
|
Accumulated
other
comprehensive
loss
|
Total
shareholders’
equity
|
Non-
controlling
interest
|
Total equity
|
||||||||||||||||||||||||||
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
Balance as of December 31, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net loss
|
-
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Acquisition of
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
|
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
Ordinary shares
|
Additional
paid in capital
|
Accumulated
deficit
|
Accumulated
other
comprehensive
loss
|
Total
shareholders’
equity
|
Non-
controlling
interest
|
Total equity
|
||||||||||||||||||||||||||
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
Balance as of December 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net loss
|
-
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Acquisition of
|
-
|
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||
Exercise of warrants
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Balance as of June 30, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Name
|
Date of
Incorporation
|
Place of
Incorporation
|
Percentage of direct or
indirect economic
interest
|
|||
Cenntro Automotive Corporation (“CAC”)
|
|
|
|
|||
Cenntro Electric Group, Inc. (“CEG”)
|
|
|
|
|||
Cennatic Power, Inc. (“Cennatic Power”)
|
|
|
|
|||
Teemak Power Corporation
|
|
|
|
|||
Avantier Motors Corporation
|
|
|
|
|||
Cenntro Electric CICS, SRL
|
|
|
|
|||
Cennatic Energy S. de R.L. de C.V.
|
|
|
|
|||
Cenntro Automotive S.A.S.
|
|
|
|
|||
Cenntro Electric Colombia S.A.S.
|
|
|
|
|||
Cenntro Automotive Group Limited (“CAG HK”)
|
|
|
|
|||
Hangzhou Ronda Tech Co., Limited (“Hangzhou Ronda”)
|
|
|
|
|||
Hangzhou Cenntro Autotech Co., Limited (“Cenntro Hangzhou”)
|
|
|
|
|||
Zhejiang Cenntro Machinery Co., Limited
|
|
|
|
|||
Jiangsu Tooniu Tech Co., Limited
|
|
|
|
|||
Hangzhou Hengzhong Tech Co., Limited
|
|
|
|
|||
Teemak Power (Hong Kong) Limited (HK)
|
|
|
|
|||
Avantier Motors (Hong Kong) Limited
|
|
|
|
|||
Cenntro Automotive Europe GmbH (“CAE”)
|
|
|
|
|||
Cenntro Electric B.V.
|
|
|
|
|||
Cenntro Elektromobilite Araçlar A.Ş
|
|
|
|
|||
Cenntro Elecautomotiv, S.L.
|
|
|
|
|||
Cenntro Electric Group (Europe) GmbH (“Cenntro Electric”)
|
|
|
|
|||
Simachinery Equipment Limited (“Simachinery HK”)
|
|
|
|
|||
Zhejiang Sinomachinery Co., Limited (“Sinomachinery Zhejiang”)
|
|
|
|
|||
Shengzhou Cenntro Machinery Co., Limited (“Cenntro Machinery”)
|
|
|
|
|||
Cenntro EV Center Italy S.R.L.
|
|
|
|
(a) |
Basis of presentation
|
(b) |
Use of estimates
|
(c) |
Revenue recognition
|
For the Six Months
Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
Vehicles sales
|
$
|
|
$
|
|
||||
Spare-parts sales
|
|
|
||||||
Other service income
|
|
|
||||||
Net revenues
|
$
|
|
$
|
|
For the Six Months
Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
Primary geographical markets
|
|
|||||||
Europe
|
$
|
|
$
|
|
||||
Asia
|
|
|
||||||
America
|
|
|
||||||
Total
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
Accounts receivable, net
|
$
|
|
$
|
|
||||
Contractual liabilities
|
$
|
|
$
|
|
(d) |
Recently issued accounting standards pronouncement
|
June 30,
2023
|
December 31,
2022
|
|||||||
Accounts receivable
|
$
|
|
$
|
|
||||
Less: provision for doubtful accounts
|
(
|
)
|
(
|
)
|
||||
Accounts receivable, net
|
$
|
|
$
|
|
For the Six Months
Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
Balance at the beginning of the period
|
$
|
|
$
|
|
||||
Additions
|
|
|
||||||
Write-off
|
(
|
)
|
(
|
)
|
||||
Foreign exchange
|
|
(
|
)
|
|||||
Balance at the end of the year
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
Raw material
|
$
|
|
$
|
|
||||
Work-in-progress
|
|
|
||||||
Goods in transit
|
|
|
||||||
Finished goods
|
|
|
||||||
Inventories
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
Advance to suppliers
|
$
|
|
$
|
|
||||
Deductible input value added tax
|
|
|
||||||
Receivable from third parties
|
|
|
||||||
Loans to a third party
|
|
|
||||||
Others
|
|
|
||||||
Prepayment and other current assets
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
Antric GmbH (1)
|
$
|
|
$
|
|
||||
Hangzhou Entropy Yu Equity Investment Partnership (Limited Partnership) (“Entropy Yu”) (2)
|
|
|
||||||
Hangzhou Hezhe Energy Technology Co., Ltd. (“Hangzhou Hezhe”) (3)
|
|
|
||||||
Able 2rent GmbH (DEU) (4)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
June 30,
2023
|
December 31,
2022
|
|||||||
HW Electro Co., Ltd. (1)
|
$ |
|
$ |
|
||||
Total
|
$
|
|
$
|
|
(1) |
|
June 30,
2023
|
December 31,
2022
|
|||||||
MineOne Fix Income Investment I L.P
|
$
|
|
$
|
|
||||
Micro Money Fund SPC
|
|
|
||||||
Total
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
At cost:
|
||||||||
Plant and building (1)
|
$
|
|
$
|
|
||||
Machinery and equipment
|
|
|
||||||
Leasehold improvement
|
|
|
||||||
Office equipment
|
|
|
||||||
Motor vehicles
|
|
|
||||||
Property, plant and equipment, gross
|
|
|
||||||
Less: accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Property, plant and equipment, net
|
$
|
|
$
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
At cost:
|
||||||||
Land use right
|
$
|
|
$
|
|
||||
Software
|
|
|
||||||
Total
|
|
|
||||||
Less: accumulated amortization
|
(
|
)
|
(
|
)
|
||||
Intangible assets, net
|
$
|
|
$
|
|
For the Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
PRC
|
$
|
|
|
|||||
US
|
|
|
||||||
Australia
|
|
|
||||||
Europe |
|
|
||||||
Others
|
|
|
||||||
Total
|
$
|
|
|
For the Six Months
Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
Operating leases cost excluding short-term rental expense
|
$
|
|
$
|
|
||||
Short-term lease cost
|
|
|
||||||
Total
|
$
|
|
$
|
|
June 30,
2023
|
June 30,
2022
|
|||||||
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
|
$
|
|
||||
Weighted average remaining lease term
|
|
|
||||||
Weighted average discount rate
|
|
%
|
|
%
|
Operating
Leases
|
||||
For the remaining of 2023
|
$
|
|
||
Years ended December 31,
|
||||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028 and thereafter
|
|
|||
Total lease payments
|
|
|||
Less: imputed interest
|
|
|||
Total
|
|
|||
Less: current portion
|
|
|||
Non-current portion
|
$
|
|
Liability component
|
||||
As of December 31, 2022
|
$
|
|
||
Convertible promissory notes issued during the year
|
|
|||
Redemption of convertible promissory notes
|
(
|
)
|
||
Fair value change recognized
|
|
|||
As of June 30, 2023
|
|
Fair Value Assumptions - Convertible Promissory Note
|
June 30,
2023
|
December 31,
2022
|
||||||
Face value principal payable
|
|
|
||||||
Original conversion price
|
|
|
||||||
Interest Rate
|
|
%
|
|
%
|
||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Market yield (range)
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
||||
Issue date
|
|
|
||||||
Maturity date
|
|
|
Investor warrants
component
|
Placement agent
warrants component
|
|||||||
As of December 31, 2022
|
$
|
|
$
|
|
||||
Warrants issued during the year
|
|
|
||||||
Exercise of warrants
|
(
|
)
|
|
|||||
Fair value change recognized
|
(
|
)
|
(
|
)
|
||||
As of June 30, 2023
|
|
|
Fair Value Assumptions – Warrants
|
June 30,
2023
|
December 31,
2022
|
||||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
(a) |
Customers
|
Six months ended
|
Six months ended
|
|||||||||||||||
June 30, 2023,
|
June 30, 2022,
|
|||||||||||||||
Customer
|
Amount
|
% of Total |
Amount
|
% of Total |
||||||||||||
A
|
$ |
|
|
%
|
$ |
|
|
%
|
||||||||
B
|
|
|
|
|
%
|
|||||||||||
C
|
|
|
|
|
%
|
|||||||||||
D
|
|
|
|
|
%
|
|||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
* |
|
As of June 30, 2023,
|
As of December 31, 2022,
|
|||||||||||||||
Customer |
Amount
|
% of Total |
Amount
|
% of Total |
||||||||||||
C |
$
|
|
|
%
|
$
|
|
|
|||||||||
D |
|
|
|
%
|
||||||||||||
E |
|
|
%
|
|
||||||||||||
F |
|
|
%
|
|
|
%
|
||||||||||
G |
% | % | ||||||||||||||
Total |
$
|
|
|
%
|
$
|
|
|
%
|
* |
Indicates below 10%.
|
(b) |
Suppliers
|
Six months ended
June 30, 2023,
|
Six months ended
June 30, 2022,
|
|||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
|||||||||
B
|
|
|
%
|
|
|
|||||||||||
C |
% | |||||||||||||||
D |
% | |||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
* |
Indicates below 10%.
|
As of June 30, 2023,
|
As of December 31, 2022,
|
|||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
E
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
D
|
|
|
%
|
|
|
%
|
||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
Name of related parties:
|
Relationship with the Company
|
|
Mr. Yeung Heung Yeung
|
|
|
Shenzhen Yuanzheng Investment Development Co. Ltd (“Shenzhen Yuanzheng“)
|
|
|
Zhejiang RAP
|
|
|
Jiangsu Rongyuan
|
|
|
Hangzhou Hezhe Energy Technology Co., Ltd (“Hangzhou Hezhe”)
|
|
|
Bendon Limited | ||
Shanghai Hengyu Enterprise Management Consulting Co., Ltd (“Shanghai Hengyu”)
|
|
|
Antric GmbH
|
|
For the Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
|
||||||||
Zhejiang RAP
|
$ |
|
$ |
|
||||
Bendon Limited
|
|
|||||||
Purchase of raw materials from related parties
|
||||||||
Hangzhou Hezhe
|
|
|
|
|
||||
Service provided by a related party
|
||||||||
Shanghai Hengyu
|
|
|||||||
Zhejiang Zhongchai
|
|
|||||||
|
||||||||
Mr. Yeung Heung Yeung
|
|
|
||||||
Others |
|
|||||||
Payment on the purchase of the raw materials
|
||||||||
Hangzhou Hezhe
|
|
|||||||
Repayment of interest-bearing Loan from related parties
|
||||||||
Shenzhen Yuanzheng |
||||||||
Yeung Hueng Yeung |
June 30,
2023
|
December 31,
2022
|
|||||||
Hangzhou Hezhe (1)
|
$ |
|
$ |
|
||||
Total
|
$ |
|
$ |
|
(1) |
|
June 30,
2023
|
December 31,
2022
|
|||||||
Zhejiang RAP
|
$
|
|
$
|
|
||||
Jiangsu Rongyuan
|
|
|
||||||
Shanghai Hengyu
|
|
|
||||||
Antric GmbH
|
|
|
||||||
Total
|
$
|
|
$
|
|
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Six Months ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|||||||
Gross margin of vehicle sales
|
16.7
|
%
|
8.7
|
%
|
Three Months ended June 30,
|
Six Months ended June 30,
|
|||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||
Combined Statements of Operations Data:
|
||||||||||||||||
Net revenues
|
4,237,520
|
3,204,689
|
7,708,064
|
5,035,322
|
||||||||||||
Cost of goods sold
|
(3,090,275
|
)
|
(3,036,237
|
)
|
(6,366,075
|
)
|
(4,503,840
|
)
|
||||||||
Gross profit/(loss)
|
1,147,245
|
168,452
|
1,341,989
|
531,482
|
||||||||||||
Operating Expenses:
|
||||||||||||||||
Selling and marketing expenses
|
(2,742,749
|
)
|
(1,531,460
|
)
|
(4,611,734
|
)
|
(2,626,568
|
)
|
||||||||
General and administrative expenses
|
(9,285,213
|
)
|
(12,014,453
|
)
|
(16,643,477
|
)
|
(20,226,284
|
)
|
||||||||
Research and development expenses
|
(2,143,070
|
)
|
(1,389,153
|
)
|
(3,712,989
|
)
|
(1,814,512
|
)
|
||||||||
Total operating expenses
|
(14,171,032
|
)
|
(14,935,066
|
)
|
(24,968,200
|
)
|
(24,667,364
|
)
|
||||||||
Loss from operations
|
(13,023,787
|
)
|
(14,766,614
|
)
|
(23,626,211
|
)
|
(24,135,882
|
)
|
||||||||
Other Income (Expense):
|
||||||||||||||||
Interest expense, net
|
1,262
|
222,672
|
(53,153
|
)
|
286,873
|
|||||||||||
(Loss) Income from equity method investments
|
(148,645
|
)
|
4,941
|
(129,603
|
)
|
10,878
|
||||||||||
Other (expense) income, net
|
(1,119,295
|
)
|
784,220
|
(761,219
|
)
|
734,981
|
||||||||||
Loss on redemption of convertible promissory notes
|
1,900
|
(101
|
)
|
-
|
||||||||||||
Loss on exercise of warrants
|
(14,745
|
)
|
(227,615
|
)
|
-
|
|||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
199,698
|
73,425
|
-
|
|||||||||||||
Change in fair value of equity securities
|
60,452
|
713,468
|
-
|
|||||||||||||
Impairment of Long-term investments
|
(8,538
|
)
|
(1,154,666
|
)
|
-
|
|||||||||||
Loss before income taxes
|
(14,051,698
|
)
|
(13,754,781
|
)
|
(25,165,675
|
)
|
(23,103,150
|
)
|
||||||||
Income tax expense
|
(25,468
|
)
|
48,861
|
(25,468
|
)
|
48,861
|
||||||||||
Net loss
|
(14,077,166
|
)
|
(13,705,920
|
)
|
(25,191,143
|
)
|
(23,054,289
|
)
|
||||||||
Less: net loss attributable to non-controlling interests
|
(2,682
|
)
|
(633,922
|
)
|
(158,710
|
)
|
(670,641
|
)
|
||||||||
Net loss attributable to shareholders of the Company
|
(14,074,484
|
)
|
(13,071,998
|
)
|
(25,032,433
|
)
|
(22,383,648
|
)
|
Three Months ended June 30,
|
Six Months ended June 30,
|
|||||||||||||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||||||||||||||||||
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
|||||||||||||||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||||||||||||||||
Net revenues:
|
||||||||||||||||||||||||||||||||
Vehicle Sales
|
$
|
4,385,086
|
103.5
|
%
|
$
|
3,134,559
|
97.8
|
%
|
$
|
7,226,049
|
93.7
|
%
|
$
|
4,852,930
|
96.4
|
%
|
||||||||||||||||
Spare-part sales
|
-253,334
|
-6.0
|
%
|
-16,798
|
-0.5
|
%
|
344,702
|
4.5
|
%
|
84,626
|
1.7
|
%
|
||||||||||||||||||||
Other sales
|
105,768
|
2.5
|
%
|
86,928
|
2.7
|
%
|
137,313
|
1.8
|
%
|
97,766
|
1.9
|
%
|
||||||||||||||||||||
Total net revenues
|
$
|
4,237,520
|
$
|
3,204,689
|
100.00
|
%
|
$
|
7,708,064
|
100.00
|
%
|
$
|
5,035,322
|
100.00
|
%
|
Three Months ended June 30,
|
Six Months ended June 30,
|
|||||||||||||||||||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||||||||||||||||||
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
|||||||||||||||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||||||||||||||||
Cost of goods sold:
|
||||||||||||||||||||||||||||||||
Vehicle Sales
|
$
|
(3,228,346
|
)
|
104.5
|
%
|
$
|
(2,452,858
|
)
|
80.8
|
%
|
$
|
(6,023,108
|
)
|
94.6
|
%
|
$
|
(3,832,462
|
)
|
85.1
|
%
|
||||||||||||
Spare-part sales
|
263,139
|
-8.5
|
%
|
51,385
|
-1.7
|
%
|
(201,085
|
)
|
3.2
|
%
|
(46,639
|
)
|
1.0
|
%
|
||||||||||||||||||
Other sales
|
(125,068
|
)
|
4.0
|
%
|
(36,297
|
)
|
1.2
|
%
|
(141,882
|
)
|
2.2
|
%
|
(26,272
|
)
|
0.6
|
%
|
||||||||||||||||
Inventory write-down
|
(598,467
|
)
|
19.7
|
%
|
-
|
-
|
(598,467
|
)
|
13.3
|
%
|
||||||||||||||||||||||
Total cost of goods sold
|
$
|
(3,090,275
|
)
|
100.00
|
%
|
(3,036,237
|
)
|
100.00
|
%
|
$
|
(6,366,075
|
)
|
100.00
|
%
|
$
|
(4,503,840
|
)
|
100.00
|
%
|
• |
as a measurement of operating performance because it assists us in comparing the operating performance of our business on a consistent basis, as it removes the impact of items not directly resulting from our core operations;
|
• |
for planning purposes, including the preparation of our internal annual operating budget and financial projections;
|
• |
to evaluate the performance and effectiveness of our operational strategies; and
|
• |
to evaluate our capacity to expand our business.
|
• |
such measures do not reflect our cash expenditures;
|
• |
such measures do not reflect changes in, or cash requirements for, our working capital needs;
|
• |
although depreciation and amortization are recurring, non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such replacements;
and
|
• |
the exclusion of stock-based compensation expense, which has been a significant recurring expense and will continue to constitute a significant recurring expense for the foreseeable future, as equity awards are expected to continue to be
an important component of our compensation strategy.
|
|
Three Months ended June 30,
|
Six Months ended June 30,
|
||||||||||||||
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||
Net loss
|
$
|
(14,077,166
|
)
|
$
|
(13,705,920
|
)
|
$
|
(25,191,143
|
)
|
$
|
(23,054,289
|
)
|
||||
Interest expense, net
|
(1,262
|
)
|
(222,672
|
)
|
53,153
|
(286,873
|
)
|
|||||||||
Income tax expense
|
25,468
|
(48,861
|
)
|
25,468
|
(48,861
|
)
|
||||||||||
Depreciation and amortization
|
455,779
|
344,507
|
786,411
|
484,937
|
||||||||||||
Share-based compensation expense
|
1,256,484
|
1,110,440
|
2,410,291
|
1,309,856
|
||||||||||||
Loss on redemption of convertible promissory notes
|
(1,900
|
)
|
101
|
-
|
||||||||||||
Loss on exercise of warrants
|
14,745
|
227,615
|
||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
(199,697
|
)
|
(73,425
|
)
|
-
|
|||||||||||
Expenses related to TME Acquisition
|
348,987
|
348,987
|
||||||||||||||
Expenses related to one-off payment inherited from the original Naked Brand Group
|
8,299,178
|
|||||||||||||||
Adjusted EBITDA
|
(12,527,549
|
)
|
(12,173,520
|
)
|
$
|
(21,761,529
|
)
|
$
|
(12,947,065
|
)
|
• |
The costs of bringing our new facilities into operation;
|
• |
The timing and costs involved in rolling out new ECV models to market;
|
• |
Our ability to manage the costs of manufacturing our ECVs;
|
• |
The costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;
|
• |
Revenues received from sales of our ECVs;
|
• |
The costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;
|
• |
Our ability to collect future revenues; and
|
• |
Other risks discussed in the section titled “Risk Factors.”
|
Six Months Ended June 30,
|
||||||||
2023
|
2022
|
|||||||
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|||||||
Net cash used in operating activities
|
$
|
(35,499,138
|
)
|
$
|
(29,071,262
|
)
|
||
Net cash (used in) provided by investing activities
|
(9,988,522
|
)
|
(17,112,002
|
)
|
||||
Net cash provided by financing activities
|
(45,583,321
|
)
|
(30,960,641
|
)
|
||||
Effect of exchange rate changes on cash
|
(2,543,188
|
)
|
(981,467
|
)
|
||||
Net (decrease) increase in cash, cash equivalents, and restricted cash
|
(93,614,168
|
)
|
(78,125,372
|
)
|
||||
Cash and cash equivalents, and restricted cash at beginning of the year
|
154,096,801
|
261,664,962
|
||||||
Cash and cash equivalents, and restricted cash at end of the period
|
$
|
60,482,633
|
$
|
183,539,590
|
For the Six Months Ended June
30, |
||||||||
2023
|
2022
|
|||||||
Vehicles sales
|
|
$
|
7,226,049
|
|
|
$
|
4,852,930
|
|
Spare-parts sales
|
|
|
344,702
|
|
|
|
84,626
|
|
Other service income
|
|
|
137,313
|
|
|
|
97,766
|
|
Net revenues
|
|
$
|
7,708,064
|
|
|
$
|
5,035,322
|
|
For the Six Months Ended June
30,
|
||||||||
2023
|
2022
|
|||||||
Primary geographical markets
|
|
|
|
|
||||
Europe
|
$
|
5,531,486
|
$
|
2,963,630
|
||||
Asia
|
2,079,876
|
1,644,209
|
||||||
America
|
|
|
96,702
|
|
|
|
427,483
|
|
Total
|
|
$
|
7,708,064
|
|
|
$
|
5,035,322
|
|
June 30,
2023
|
December 31,
2022
|
|||||||
Accounts receivable, net
|
$
|
2,646,333
|
$
|
565,398
|
||||
Contractual liabilities
|
$
|
3,314,661
|
$
|
2,388,480
|
For the Periods Ended
|
||||||||||||||||||||||||
Unaudited 30 June 2023
|
31 December 2022
|
|||||||||||||||||||||||
Balance Sheet:
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
||||||||||||||||||
Current assets
|
||||||||||||||||||||||||
Cash and cash equivalents
|
60,390,172
|
-
|
60,390,172
|
153,966,777
|
-
|
153,966,777
|
||||||||||||||||||
Restricted cash
|
92,461
|
-
|
92,461
|
130,024
|
-
|
130,024
|
||||||||||||||||||
Accounts receivable, net
|
2,646,333
|
-
|
2,646,333
|
565,398
|
-
|
565,398
|
||||||||||||||||||
Inventories
|
41,798,511
|
-
|
41,798,511
|
31,843,371
|
-
|
31,843,371
|
||||||||||||||||||
Prepayment and other current assets
|
18,339,914
|
-
|
18,339,914
|
16,138,330
|
-
|
16,138,330
|
||||||||||||||||||
Deferred cost-current
|
10,273
|
-
|
10,273
|
-
|
-
|
-
|
||||||||||||||||||
Amount due from a related party
|
212,320
|
-
|
212,320
|
366,936
|
-
|
366,936
|
||||||||||||||||||
Total current assets
|
123,489,984
|
-
|
123,489,984
|
203,010,836
|
-
|
203,010,836
|
||||||||||||||||||
Non-current assets
|
||||||||||||||||||||||||
Long-term investment, net
|
4,959,769
|
-
|
4,959,769
|
5,325,741
|
-
|
5,325,741
|
||||||||||||||||||
Investment in equity securities
|
30,472,663
|
-
|
30,472,663
|
29,759,195
|
-
|
29,759,195
|
||||||||||||||||||
Property, plant and equipment, net
|
18,508,847
|
-
|
18,508,847
|
14,962,591
|
-
|
14,962,591
|
||||||||||||||||||
Intangible assets, net
|
6,439,333
|
-
|
6,439,333
|
4,563,792
|
-
|
4,563,792
|
||||||||||||||||||
Right-of-use assets
|
19,734,961
|
-
|
19,734,961
|
8,187,149
|
-
|
8,187,149
|
||||||||||||||||||
Deferred cost - non-current
|
207,974
|
-
|
207,974
|
-
|
-
|
-
|
||||||||||||||||||
Other non-current assets, net
|
2,232,206
|
-
|
2,232,206
|
2,039,012
|
-
|
2,039,012
|
||||||||||||||||||
Total non-current assets
|
82,555,753
|
-
|
82,555,753
|
64,837,480
|
-
|
64,837,480
|
||||||||||||||||||
Total assets
|
206,045,737
|
-
|
206,045,737
|
267,848,316
|
-
|
267,848,316
|
||||||||||||||||||
Current liabilities
|
||||||||||||||||||||||||
Accounts payable
|
3,364,228
|
-
|
3,364,228
|
3,383,021
|
-
|
3,383,021
|
||||||||||||||||||
Accrued expense and other current liabilities
|
3,543,840
|
-
|
3,543,840
|
5,048,641
|
-
|
5,048,641
|
||||||||||||||||||
Contractual liabilities
|
3,314,661
|
-
|
3,314,661
|
2,388,480
|
-
|
2,388,480
|
||||||||||||||||||
Operating lease liabilities, current
|
4,303,890
|
-
|
4,303,890
|
1,313,334
|
-
|
1,313,334
|
||||||||||||||||||
Convertible promissory notes
|
11,904,153
|
-
|
11,904,153
|
57,372,827
|
-
|
57,372,827
|
||||||||||||||||||
Deferred government grant, current
|
53,046
|
-
|
53,046
|
26,533
|
-
|
26,533
|
||||||||||||||||||
Amount due to related parties
|
41,302
|
-
|
41,302
|
716,372
|
-
|
716,372
|
||||||||||||||||||
Total current liabilities
|
26,525,120
|
-
|
26,525,120
|
70,249,208
|
-
|
70,249,208
|
||||||||||||||||||
Non-current liabilities
|
||||||||||||||||||||||||
Deferred government grant, non-current
|
968,079
|
-
|
968,079
|
497,484
|
-
|
497,484
|
||||||||||||||||||
Derivative liability - investor warrant
|
12,205,830
|
-
|
12,205,830
|
14,334,104
|
-
|
14,334,104
|
||||||||||||||||||
Derivative liability - placement agent warrant
|
3,456,137
|
-
|
3,456,137
|
3,456,404
|
-
|
3,456,404
|
||||||||||||||||||
Operating lease liabilities, non-current
|
16,001,387
|
-
|
16,001,387
|
7,421,582
|
-
|
7,421,582
|
||||||||||||||||||
Total non-current liabilities
|
32,631,433
|
-
|
32,631,433
|
25,709,574
|
-
|
25,709,574
|
||||||||||||||||||
Total liabilities
|
59,156,553
|
-
|
59,156,553
|
95,958,782
|
-
|
95,958,782
|
||||||||||||||||||
Equity
|
||||||||||||||||||||||||
Ordinary shares (No par value; 304,449,091 and 300,841,995 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Additional paid-in capital
|
399,517,411
|
182,274,066
|
(1)
|
581,791,477
|
397,497,817
|
182,125,475
|
(1)
|
579,623,292
|
||||||||||||||||
Accumulated other comprehensive loss
|
(7,770,097
|
)
|
7,770,097
|
-
|
(5,306,972
|
)
|
5,306,972
|
-
|
||||||||||||||||
Reserves
|
-
|
19,385,768
|
(2)
|
19,385,768
|
-
|
21,997,484
|
(2)
|
21,997,484
|
||||||||||||||||
Accumulated deficit
|
(244,856,609
|
)
|
(209,429,931
|
)
|
(454,286,540
|
)
|
(219,824,176
|
)
|
(209,429,931
|
)
|
(429,254,107
|
)
|
||||||||||||
Total Stockholders' Equity
|
146,890,705
|
-
|
146,890,705
|
172,366,669
|
-
|
172,366,669
|
||||||||||||||||||
Non-controlling interests
|
(1,521
|
)
|
-
|
(1,521
|
)
|
(477,135
|
)
|
-
|
(477,135
|
)
|
||||||||||||||
Total Equity
|
146,889,184
|
-
|
146,889,184
|
171,889,534
|
-
|
171,889,534
|
||||||||||||||||||
Total Liabilities and Equity
|
206,045,737
|
-
|
206,045,737
|
267,848,316
|
-
|
267,848,316
|
(1) |
Includes (i) $(29,714,747) (2022: $(27,304,456)) in share-based compensation payments. (ii) $2,558,882 recognized in 2023 from the acquisition of 35% of CAE’s equity interest, and (iii) additional equity of $209,429,931 recognized in
2021 from the difference between the deemed transaction price and net assets acquired related to the Combination under IFRS.
|
(2) |
Includes (i) a reclassification of Accumulated other comprehensive loss under U.S. GAAP of $(7,770,097) (2022: $(5,306,972)), (ii) a reclassification of Additional paid-in capital under U.S. GAAP of $29,714,747 (2022: $27,304,456) in
share-based compensation payments to Reserves under IFRS, and (iii) a reclassification of Additional paid-in capital under U.S. GAAP of $(2,558,882) recognized in 2023 from the acquisition of 35% of CAE’s equity interest to Reserve under
IFRS.
|
For the Three Months Ended
|
||||||||||||||||||||||||
Unaudited 30 June 2023
|
Unaudited 30 June 2022
|
|||||||||||||||||||||||
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
||||||||||||||||||
Net revenues
|
4,237,520
|
-
|
4,237,520
|
3,204,689
|
-
|
3,204,689
|
||||||||||||||||||
Cost of goods sold
|
(3,090,275
|
)
|
-
|
(3,090,275
|
)
|
(3,036,237
|
)
|
-
|
(3,036,237
|
)
|
||||||||||||||
Gross profit
|
1,147,245
|
-
|
1,147,245
|
168,452
|
-
|
168,452
|
||||||||||||||||||
|
||||||||||||||||||||||||
Selling and marketing expenses
|
(2,742,749
|
)
|
-
|
(2,742,749
|
)
|
(1,531,460
|
)
|
-
|
(1,531,460
|
)
|
||||||||||||||
General and administrative expenses
|
(9,285,213
|
)
|
-
|
(9,285,213
|
)
|
(12,014,453
|
)
|
-
|
(12,014,453
|
)
|
||||||||||||||
Research and development expenses
|
(2,143,070
|
)
|
-
|
(2,143,070
|
)
|
(1,389,153
|
)
|
-
|
(1,389,153
|
)
|
||||||||||||||
Total operating expenses
|
(14,171,032
|
)
|
-
|
(14,171,032
|
)
|
(14,935,066
|
)
|
-
|
(14,935,066
|
)
|
||||||||||||||
|
||||||||||||||||||||||||
Loss from operations
|
(13,023,787
|
)
|
-
|
(13,023,787
|
)
|
(14,766,614
|
)
|
-
|
(14,766,614
|
)
|
||||||||||||||
|
||||||||||||||||||||||||
Interest income (expense), net
|
1,262
|
-
|
1,262
|
222,672
|
-
|
222,672
|
||||||||||||||||||
(Loss) income from long-term investment
|
(148,645
|
)
|
-
|
(148,645
|
)
|
4,941
|
-
|
4,941
|
||||||||||||||||
Impairment of long-term investment
|
(8,538
|
)
|
(8,538
|
)
|
-
|
-
|
-
|
|||||||||||||||||
Gain (loss) on redemption of convertible promissory notes
|
1,900
|
-
|
1,900
|
-
|
-
|
-
|
||||||||||||||||||
Loss on exercise of warrants
|
(14,745
|
)
|
-
|
(14,745
|
)
|
-
|
-
|
-
|
||||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
199,698
|
-
|
199,698
|
-
|
-
|
-
|
||||||||||||||||||
Change in fair value of equity securities
|
60,452
|
60,452
|
-
|
-
|
-
|
|||||||||||||||||||
Other (expense) income, net
|
(1,119,295
|
)
|
-
|
(1,119,295
|
)
|
784,220
|
-
|
784,220
|
||||||||||||||||
Loss before income taxes
|
(14,051,698
|
)
|
-
|
(14,051,698
|
)
|
(13,754,781
|
)
|
-
|
(13,754,781
|
)
|
||||||||||||||
Income tax expense
|
(25,468
|
)
|
-
|
(25,468
|
)
|
48,861
|
-
|
48,861
|
||||||||||||||||
Net loss
|
(14,077,166
|
)
|
-
|
(14,077,166
|
)
|
(13,705,920
|
)
|
-
|
(13,705,920
|
)
|
||||||||||||||
Less: net loss attributable to non-controlling interests
|
(2,682
|
)
|
-
|
(2,682
|
)
|
(633,922
|
)
|
-
|
(633,922
|
)
|
||||||||||||||
Net loss attributable to the Company’s shareholders
|
(14,074,484
|
)
|
-
|
(14,074,484
|
)
|
(13,071,998
|
)
|
-
|
(13,071,998
|
)
|
||||||||||||||
|
-
|
|||||||||||||||||||||||
Other comprehensive loss
|
-
|
|||||||||||||||||||||||
Foreign currency translation adjustment
|
(2,824,971
|
)
|
-
|
(2,824,971
|
)
|
(4,078,240
|
)
|
-
|
(4,078,240
|
)
|
||||||||||||||
Total comprehensive loss
|
(16,902,137
|
)
|
-
|
(16,902,137
|
)
|
(17,784,160
|
)
|
-
|
(17,784,160
|
)
|
||||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(2,683
|
)
|
-
|
(2,683
|
)
|
(483,216
|
)
|
-
|
(483,216
|
)
|
||||||||||||||
Total comprehensive loss attributable to the Company’s shareholders
|
(16,899,454
|
)
|
-
|
(16,899,454
|
)
|
(17,300,944
|
)
|
-
|
(17,300,944
|
)
|
|
For the Six Months Ended
|
|||||||||||||||||||||||
|
Unaudited 30 June 2023
|
Unaudited 30 June 2022
|
||||||||||||||||||||||
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
||||||||||||||||||
Net revenues
|
7,708,064
|
-
|
7,708,064
|
5,035,322
|
-
|
5,035,322
|
||||||||||||||||||
Cost of goods sold
|
(6,366,075
|
)
|
-
|
(6,366,075
|
)
|
(4,503,840
|
)
|
-
|
(4,503,840
|
)
|
||||||||||||||
Gross (Loss) Profit
|
1,341,989
|
-
|
1,341,989
|
531,482
|
-
|
531,482
|
||||||||||||||||||
|
||||||||||||||||||||||||
Selling and marketing expenses
|
(4,611,734
|
)
|
-
|
(4,611,734
|
)
|
(2,626,568
|
)
|
-
|
(2,626,568
|
)
|
||||||||||||||
General and administrative expenses
|
(16,643,477
|
)
|
-
|
(16,643,477
|
)
|
(20,226,284
|
)
|
-
|
(20,226,284
|
)
|
||||||||||||||
Research and development expenses
|
(3,712,989
|
)
|
-
|
(3,712,989
|
)
|
(1,814,512
|
)
|
-
|
(1,814,512
|
)
|
||||||||||||||
Total operating expenses
|
(24,968,200
|
)
|
-
|
(24,968,200
|
)
|
(24,667,364
|
)
|
-
|
(24,667,364
|
)
|
||||||||||||||
|
||||||||||||||||||||||||
Loss from operations
|
(23,626,211
|
)
|
-
|
(23,626,211
|
)
|
(24,135,882
|
)
|
-
|
(24,135,882
|
)
|
||||||||||||||
|
||||||||||||||||||||||||
Interest (expense) income, net
|
(53,153
|
)
|
-
|
(53,153
|
)
|
286,873
|
-
|
286,873
|
||||||||||||||||
(Loss) income from long-term investment
|
(129,603
|
)
|
-
|
(129,603
|
)
|
10,878
|
-
|
10,878
|
||||||||||||||||
Impairment of long-term investment
|
(1,154,666
|
)
|
(1,154,666
|
)
|
-
|
-
|
-
|
|||||||||||||||||
Loss on redemption of convertible promissory notes
|
(101
|
)
|
-
|
(101
|
)
|
-
|
-
|
-
|
||||||||||||||||
Loss on exercise of warrants
|
(227,615
|
)
|
(227,615
|
)
|
-
|
-
|
-
|
|||||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
73,425
|
-
|
73,425
|
-
|
-
|
-
|
||||||||||||||||||
Change in fair value of equity securities
|
713,468
|
713,468
|
-
|
-
|
-
|
|||||||||||||||||||
Other (expense) income, net
|
(761,219
|
)
|
-
|
(761,219
|
)
|
734,981
|
-
|
734,981
|
||||||||||||||||
Loss before income taxes
|
(25,165,675
|
)
|
-
|
(25,165,675
|
)
|
(23,103,150
|
)
|
-
|
(23,103,150
|
)
|
||||||||||||||
Income tax expense
|
(25,468
|
)
|
-
|
(25,468
|
)
|
48,861
|
-
|
48,861
|
||||||||||||||||
Net loss
|
(25,191,143
|
)
|
-
|
(25,191,143
|
)
|
(23,054,289
|
)
|
-
|
(23,054,289
|
)
|
||||||||||||||
Less: net loss attributable to non-controlling interests
|
(158,710
|
)
|
-
|
(158,710
|
)
|
(670,641
|
)
|
-
|
(670,641
|
)
|
||||||||||||||
Net loss attributable to the Company’s shareholders
|
(25,032,433
|
)
|
-
|
(25,032,433
|
)
|
(22,383,648
|
)
|
-
|
(22,383,648
|
)
|
||||||||||||||
|
-
|
|||||||||||||||||||||||
Other comprehensive loss
|
-
|
|||||||||||||||||||||||
Foreign currency translation adjustment
|
(2,487,693
|
)
|
-
|
(2,487,693
|
)
|
(3,825,086
|
)
|
-
|
(3,825,086
|
)
|
||||||||||||||
Total comprehensive loss
|
(27,678,836
|
)
|
-
|
(27,678,836
|
)
|
(26,879,375
|
)
|
-
|
(26,879,375
|
)
|
||||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(183,278
|
)
|
-
|
(183,278
|
)
|
(540,805
|
)
|
-
|
(540,805
|
)
|
||||||||||||||
Total comprehensive loss attributable to the Company’s shareholders
|
(27,495,558
|
)
|
-
|
(27,495,558
|
)
|
(26,338,570
|
)
|
-
|
(26,338,570
|
)
|
a) |
The reclassification of “Accumulated other comprehensive loss” under U.S. GAAP to “Reserves” under IFRS;
|
b) |
The reclassification of amounts of share-based payments from “Additional paid-in capital” under U.S. GAAP to “Reserves” under IFRS;
|
c) |
The reclassification of the amount recognized from the acquisition of 35% of CAE’s equity interest from “Additional paid-in capital” under U.S. GAAP to “Reserves” under IFRS; and
|
d) |
Additional equity recognized from the difference between the total deemed transaction price and net assets acquired related to the Combination under IFRS.
|
e) |
In 2021, the Company was deemed to have incurred non-cash listing costs of approximately $209.4 million as a result of the IFRS accounting treatment of the Combination, as Cenntro was deemed to have received a 67% controlling interest in
CEGL (formerly NBG) and the Group was deemed to have incurred listing costs equaling the difference between the total deemed transaction price and total net assets. Under U.S. GAAP, the Combination is accounted for as a reverse
recapitalization, which is equivalent to the issuance of shares by Cenntro for the net assets of CEGL (formerly NBG), accompanied by a recapitalization).
|
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
ITEM 4. |
CONTROLS AND PROCEDURES
|
ITEM 1. |
LEGAL PROCEEDINGS
|
1) |
On February 6, 2023, Ronda commenced a lawsuit against Newlongma in the Hangzhou Yuhang District People's Court, under which Ronda plead for (i) the termination of the vehicle purchase orders that Ronda
placed with Newlongma on February 26, 2022; (ii) recovery of advance payments for total amount of approximately $438,702; and (iii) compensation for damages caused equal to approximately $453,290. The case mediation date was March 3, 2023
and was subsequently docketed on July 3, 2023. Since then, Newlongma filed a jurisdictional objection and the Court dismissed that jurisdictional objection. As of the date of this report on Form 10-Q, the proceeding trial date has not been
set.
|
2) |
On March 30, 2023, Ronda filed a lawsuit against Newlongma in the Hangzhou Yuhang District People's Court, pleading for compensation of damages for cost of auto parts for approximately $301,514. The case was
docketed on July 19, 2023. and the trial date was set on August 15, 2023.
|
3) |
On May 8, 2023, Newlongma filed a complaint against Ronda in the Longyan Yongding District People's Court, pleading for (i) termination of the cooperation agreement between Ronda and Newlongma; (ii) retention
of the advance payments by Ronda for total amount of approximately $543,977; and (iii) Ronda’s payment of outstanding bills for $604,396. Ronda filed a jurisdictional objection and the Court dismissed that jurisdictional objection. Ronda
has since appealed that ruling. As of the date of this report on Form 10-Q, the proceeding trial date has not been set yet.
|
ITEM 1A. |
RISK FACTORS
|
ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES
|
ITEM 4. |
MINE SAFETY DISCLOSURES
|
ITEM 5. |
OTHER INFORMATION
|
ITEM 6. |
Exhibits
|
Exhibit
No.
|
Description of Exhibit
|
|
Certification of Principal Executive Officer required by Rule 13a-14(a).
|
||
Certification of Principal Financial Officer required by Rule 13a-14(a).
|
||
Certification required by Section 1350 of Chapter 63 of Title 18 of the United States Code.
|
||
101.INS*
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL*
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB*
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104*
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)
|
* |
Filed herewith.
|
** |
Furnished herewith.
|
CENNTRO ELECTRIC GROUP LIMITED
|
||
Dated: August 14, 2023.
|
||
CENNTRO ELECTRIC GROUP LIMITED
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
||
By:
|
/s/ Edmond Cheng
|
|
Edmond Cheng
|
||
Chief Financial Officer
|
||
(Principal Accounting Officer)
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material
information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has
materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the company’s ability to record, process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial
reporting.
|
Dated: August 14, 2023
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
(Principal Executive Officer)
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material
information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has
materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the company’s ability to record, process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial
reporting.
|
Dated: August 14, 2023
|
||
By:
|
/s/ Edmond Cheng
|
|
Edmond Cheng
|
||
Chief Financial Officer
|
||
(Principal Accounting Officer and Principal Financial Officer)
|
Dated: August 14, 2023
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
By:
|
/s/ Edmond Cheng
|
|
Edmond Cheng
|
||
Chief Financial Officer
|